| |
| |
|
| Insider
Information: |
Pratt Raymond Dennis |
| Relationship: |
Chief Medical Officer |
| City: |
Downingtown |
| State: |
PA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
663,358 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,567,355 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
663,358 |
|
|
| Total
Value |
$1,567,355 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
2
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
2.0
|
0.0
|
| Percentage
Gain/Loss : |
 118.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Rockwell Medical Technologies Inc |
RMTI |
VP of Drug Development |
2020-04-26 |
353,358 |
2013-06-14 |
0 |
Premium* |
|
|
Savara Inc |
SVRA |
Chief Medical Officer |
2023-12-14 |
310,000 |
2022-11-21 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
15 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SVRA |
Savara Inc |
Chief Medical Officer |
• – – |
2023-12-14 |
4 |
A |
$0.00 |
$0 |
D/D |
150,000 |
310,000 |
0 |
- |
|
| SVRA |
Savara Inc |
Chief Medical Officer |
• – – |
2023-06-26 |
4 |
B |
$2.93 |
$19,045 |
D/D |
6,500 |
160,000 |
2.74 |
% |
|
| SVRA |
Savara Inc |
Chief Medical Officer |
• – – |
2022-12-22 |
4 |
B |
$1.54 |
$5,402 |
D/D |
3,500 |
153,500 |
2.74 |
% |
|
| SVRA |
Savara Inc |
Chief Medical Officer |
• – – |
2022-11-21 |
4 |
A |
$0.00 |
$0 |
D/D |
150,000 |
150,000 |
0 |
- |
|
| RMTI |
Rockwell Medical Technolo... |
VP of Drug Development |
• – – |
2020-04-26 |
4 |
D |
$2.27 |
$10,469 |
D/D |
(4,612) |
353,358 |
0 |
- |
|
| RMTI |
Rockwell Medical Technolo... |
Chief Medical Officer |
• – – |
2019-04-25 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
357,970 |
0 |
- |
|
| RMTI |
Rockwell Medical Technolo... |
VP of Drug Development |
• – – |
2017-06-21 |
4 |
D |
$7.20 |
$548,856 |
D/D |
(76,230) |
317,970 |
0 |
- |
|
| RMTI |
Rockwell Medical Technolo... |
VP of Drug Development |
• – – |
2017-03-21 |
4 |
A |
$0.00 |
$0 |
D/D |
68,500 |
394,200 |
0 |
- |
|
| RMTI |
Rockwell Medical Technolo... |
VP of Drug Development |
• – – |
2015-10-02 |
4 |
A |
$0.00 |
$0 |
D/D |
165,000 |
325,700 |
0 |
- |
|
| RMTI |
Rockwell Medical Technolo... |
VP of Drug Development |
• – – |
2015-08-13 |
4 |
B |
$11.54 |
$57,675 |
D/D |
5,000 |
160,700 |
2.74 |
- |
|
| RMTI |
Rockwell Medical Technolo... |
VP of Drug Development |
• – – |
2015-05-01 |
4 |
D |
$9.64 |
$334,026 |
D/D |
(34,650) |
155,700 |
0 |
- |
|
| RMTI |
Rockwell Medical Technolo... |
VP of Drug Development |
• – – |
2015-03-02 |
4 |
D |
$10.47 |
$362,786 |
D/D |
(34,650) |
190,350 |
0 |
- |
|
| RMTI |
Rockwell Medical Technolo... |
VP of Drug Development |
• – – |
2014-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
225,000 |
0 |
- |
|
| RMTI |
Rockwell Medical Technolo... |
VP of Drug Development |
• – – |
2014-01-13 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
150,000 |
0 |
- |
|
| RMTI |
Rockwell Medical Technolo... |
VP of Drug Development |
• – – |
2013-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
75,000 |
0 |
- |
|
15 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
